WAI
Top KingWin Ltd
$2.30
+2.68%
$6.3M
No data for this timeframe.
Vol
Market Cap$6.3M
Cap SizeNano Cap
SEC Reports2
Recent Activity
May 22, 2026
SEC
Top KingWin Ltd discloses a share transfer agreement to sell its wholly-owned subsidiary Guangdong Tiancheng Jinhui Ente
6-K — Impact 4/10
May 8, 2026
Insider
Liao Zhanlin was granted 27,027 shares
Director @ $2.22 ($60.0K)
May 8, 2026
Insider
Mao Dongliang was granted 13,514 shares
Executive Director @ $2.22 ($30.0K)
May 8, 2026
Insider
Yang Jie (JIEYANG) was granted 27,027 shares
Chief Financial Officer @ $2.22 ($60.0K)
Apr 24, 2026
SEC
Top KingWin Ltd (WAI) filed a 6-K to disclose its entry into the AI robotics business, focusing on distribution of third
6-K — Impact 4/10
Latest Reports
NEUTRAL
6-K
4/10
Top KingWin Ltd discloses a share transfer agreement to sell its wholly-owned subsidiary Guangdong Tiancheng Jinhui Ente
May 22, 2026
NEUTRAL
6-K
4/10
Top KingWin Ltd (WAI) filed a 6-K to disclose its entry into the AI robotics business, focusing on distribution of third
Apr 24, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 8, 2026 | Liao Zhanlin | A | $60.0K |
| May 8, 2026 | Mao Dongliang | A | $30.0K |
| May 8, 2026 | Yang Jie | A | $60.0K |
| May 8, 2026 | Li Yanna | A | $48.0K |
| May 8, 2026 | Li Yibing | A | $60.0K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
5 unique insiders with 5 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 8, 2026 | Liao Zhanlin | Director | AWARD | 27,027 | $2.22 | $60.0K |
| May 8, 2026 | Mao Dongliang | Executive Director | AWARD | 13,514 | $2.22 | $30.0K |
| May 8, 2026 | Yang Jie (JIEYANG) | Chief Financial Officer | AWARD | 27,027 | $2.22 | $60.0K |
| May 8, 2026 | Li Yanna | Director | AWARD | 21,622 | $2.22 | $48.0K |
| May 8, 2026 | Li Yibing | Director | AWARD | 27,027 | $2.22 | $60.0K |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.